Suppr超能文献

评估临床和公共卫生措施的成本效益。

Evaluating the cost-effectiveness of clinical and public health measures.

作者信息

Graham J D, Corso P S, Morris J M, Segui-Gomez M, Weinstein M C

机构信息

Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115-5924, USA.

出版信息

Annu Rev Public Health. 1998;19:125-52. doi: 10.1146/annurev.publhealth.19.1.125.

Abstract

Cost-effectiveness analysis, an analytic tool that expresses as a ratio the cost of obtaining an additional unit of health outcome, can help decision makers achieve more health protection for the same or less cost. We characterize the state of the cost-effectiveness analysis literature by reviewing how this technique is applied to various clinical and public health interventions. We describe the results of cost-effectiveness analyses for over 40 interventions to reduce cancer, heart disease, trauma, and infectious disease. The cost-effectiveness ratios for these interventions vary enormously, from interventions that save money to those that cost more than $1 million per year of life gained. The methods used to derive the cost-effectiveness ratios also vary considerably, and we summarize this variation within each health area. Greater uniformity of analytical practice will be necessary if cost-effectiveness analysis is to become a more influential tool in debates about resource allocation.

摘要

成本效益分析是一种将获得额外一单位健康结果的成本表示为比率的分析工具,它可以帮助决策者以相同或更低的成本实现更多的健康保护。我们通过回顾这种技术如何应用于各种临床和公共卫生干预措施来描述成本效益分析文献的现状。我们描述了40多种减少癌症、心脏病、创伤和传染病的干预措施的成本效益分析结果。这些干预措施的成本效益比率差异巨大,从节省资金的干预措施到每获得一年生命需要花费超过100万美元的干预措施都有。用于得出成本效益比率的方法也有很大差异,我们在每个健康领域总结了这种差异。如果成本效益分析要在关于资源分配的辩论中成为一个更有影响力的工具,就需要在分析实践上有更大的一致性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验